News and media

Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).

An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.

The Australian Government is committed to immunisation and to ensuring Australia has the best possible vaccination program underpinned by sound evidence and effective vaccines.

The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.

Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.

All Australian Governments have agreed to initiate the third review of the National Scheme for the Regulation of Gene Technology (the Review). The Review will be led by a working group comprised of senior officials from Commonwealth and state and territory governments.

Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.

Australia’s therapeutic goods regulator is implementing new arrangements to simplify and improve the handling of complaints about the advertising of medicines and medical devices to the public.

An additional 800,000 influenza vaccines secured for the National Immunisation Program.

A statement from the Chief Medical Officer about Listeria.

Media statement from Australia's Chief Medical Officer, Professor Brendan Murphy regarding media claims about flu vaccines.

Two cases of multi-drug resistant gonorrhoea have been recently detected in Australia. One case was diagnosed in Western Australia and a second case diagnosed in Queensland.

The Community should be reassured that our drinking water is safe.

A statement from the Acting Chief Medical Officer about bushfire smoke.

Read the transcript of Deputy Chief Medical Officer Professor Paul Kelly's press conference about coronavirus (COVID-19).

A media release from the Victorian Aged Care Response Centre giving an update on how it is working to protect senior Australians from COVID-19.